A biguanide derivative compound with N4-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK and inhibition of cancer cell proliferation in a low dose, compared with conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.
提供一种具有N4-N5取代的
双胍衍
生物化合物,其由Formula 1表示,或其药学上可接受的盐,以及制备该化合物的方法和包含其作为活性成分的药物组合物。与传统药物相比,这种
双胍衍
生物可能在低剂量下对
AMPK的激活和癌细胞增殖的抑制效果优异,因此可能有助于治疗糖尿病、肥胖、高脂血症、高
胆固醇血症、
脂肪肝、
冠心病、骨质疏松症、多囊卵巢综合征、代谢综合征、癌症等疾病。